Gene Therapy

Thomas Mendel, MD, PhDThomas Mendel, MD, PhD

Genetics research is essential for precision-based care to provide earlier diagnosis, improve outcomes, elucidate the genetic causes of disease, and determine the best treatments and their timing for each patient. Thomas Mendel, MD, PhD, is building a genetics program to develop and implement gene therapies in patients with inherited retinal eye diseases (IRDs). Common symptoms include diminished vision in low light or night blindness, loss of color vision, light sensitivity, and vision loss.

Patients with IRDs slowly lose vision due to damaged cells in the retina and account for over 20% of blindness in adults. Dr. Mendel provides care to both adults and children, who can be affected by these diseases, in the Department of Ophthalmology and Visual Sciences at Ohio State and at Nationwide Children’s Hospital.

Learn more about clinical care: Dr. Mendel

Learn more about research: Thomas Mendel, MD, PhD

 

 

Share this page